3D bioprinting is an innovative method of manufacturing three-dimensional tissue-like structures. The method is based on a layer-by-layer deposition of biocompatible materials successively forming a scaffold for living cells. The technology allows to fabricate complicated tissue morphology, including vascular-like networks. The range of potential applications of 3D bioprinting is immense: from drug testing, across regenerative medicine, to organ transplantation. In this paper, we describe a prototype of a 3D bioprinter utilizing gelatin methacrylate (GelMA) doped with a photoinitiator as the printing substance. Biological requirements for the material, its synthesis and application adequacy for the bioprinting process are discussed. Technical details of the mechanical construction of the bioprinter and its control system are presented.
technology challenging. Various types of cells and components forming a scaffold for them were considered so far [3] . Exploiting stem cells is especially promising as it makes the implants less likely to be rejected by the organism [4] . Such cells specialize their function in a given 3D environment, potentially simplifying 3D printing of organs. Because of that number of different types of `bio-inks' needed is reduced. For reasons explained later, in our investigations we focus on the use of somatic as well as cancer cells.
The version of 3D bioprinting considered in this paper does not concern printing with cells themselves but with the suitable material forming a scaffold for the former. Such approach has been studied in various configurations in the literature (Refs. [3, 5] ). Our objective is to be able to 3D print a precisely specified scaffolding, equipped with a vascular system allowing a distribution of nutrition to the whole bulk of the obtained biomimetic composite. To this end, we constructed a prototype printer, which, layer-by-layer, deposits liquid hydrogel. The material is cured by the UV light radiation, which stiffens the structure, reproducing a given 3D morphology. The fabricated model is a base for the 3D cell culture. The technique employed for the project is analogous to the Fused Deposition Modeling (FDM) method used in commercial 3D printers. Note however, that different bio-printing methods can be considered as well, especially those utilizing piezoelectricity (often used in engineering of bio-hybrid materials [6] ) and lasers.
Our longterm goal is to develop a technology allowing the 3D bioprinting of custom scaffolds with the precision reaching 10 microns and the volume of the diameter of a typical Petri dish (60 mm) cubed. We envision many different applications of the obtained 3D bio-constructs, such as: pre-clinical drug testing, investigation of bio-toxicity of chemical components and studying various biological mechanism and processes in simplified and reproducible configurations.
The Biological Aspects. The main challenge of the presented study was to find a material optimal for 3D bioprinting. We have found that none of the commercially available materials fulfilled the following requirements: affordable, easy to process, accessible, biocompatible, flexible, biomimetic and easy to manipulate in print (fluid during the process but stiff in the cell culture). To resolve this problem we have selected agar, agarose, cellulose, silicone beads and gelatin on the basis of their non-toxicity, accessibility and low price. These were subsequently tested in various configurations and concentrations as candidates for playing the role of the scaffold for the cell cultures.
The first criterion we tested was whether the material forms a stable skeleton for cells to attach. To this end, we used the following cell culture facilities: incubation chamber, hood, cell culture plates and culture media. We chose cancer cells (murine pancreatic cancer model: Pan02) as a research model but we also selectively employed healthy renal, skin, aortic, blood, lung and brain cells.
All cells were cultured in RPMI (Roswell Park Memorial Institute) medium with 10% FBS (fetal bovine serum). The tests proved that only agar and gelatin are suitable for cell culture -only these formed a stable skeleton for cells to grow. Therefore, the other candidate materials were investigated as additives to the main substance.
Left with agar and gelatin, we begun experiments with the former. In particular, we looked for cell division and cells growing on the surface of agar [7] . What we found was that cells can grow in agar but do not attach to the agar surface. Cancer cells will create spheres but would not grow as attached cells. Therefore, healthy cells would not be able to proliferate in the agar gel. Hereby, we also confirmed that agar is not toxic to the cells. To further investigate the possibilities of agar as a main constituent of the material for 3D cell culture development, we added portions of cellulose, silicone beads and gelatin to the mixture. We hoped to create a material in which cells floating in suspension could attach to charged surfaces inside the gel. These attempts also failedthe cells didn't attach to any of the added substances. We therefore concluded that agar can be used for culturing cells in suspension and thus mostly to investigate cancer cells. Unfortunately it also means that agar cannot be used in 3D printing where we want to culture healthy cells together with cancer cells to investigate intricate biological effects.
222
Advances in Manufacturing Engineering II
The material we were left with was gelatin. Its main disadvantage comes from the fact that the cell cultures need to be kept in 37 deg C and gelatin is a fluid at this temperature. We decided to test two chemical modifications of gelatin which allow to support the whole net structure of the gel at higher temperatures: glutaraldehyde [8] and anhydrous methacrylamide [9] . Both of these substances are chemically modifying the structure of gelatin making it insoluble (in case of anhydrous methacrylamide additional initiation is needed).
First experiments showed that cells don't attach to the surface of gelatin. We started to work on different modifications of gelatin surfaces (The details are not to be revealed due to the intellectual property issues). These attempts led to the discovery of a modification procedure which gave satisfactory results. We found that cancer cells and healthy cells can grow on the modified surfaces. Thus, gelatin is suitable for 3D printing because it can be flexible during the printing process and can be also harden with a chemical reaction or a physical processes. In the prototype of the 3D bioprinter discussed below, the hydrogel network fromed by addition of the anhydrous methacrylamide photoinitiated by exposition on the UV radiation.
The Material. Having the gelatin chosen to form the 3D scaffold, we have to introduce some modifications to apply it in the printing procedure. The 3D printing requires from the material a possibility of a sudden phase change from the liquid to the solid state while the material is deposited. It is well known that the way to obtain this quality of the material one can modify gelatin by doping it with methacrylic anhydride. The suitability of the so-called gelatin methacrylate (GelMA) in fabrication of the 3D scaffolds for the biological purposes has been presented in Ref. [10] . In our case, the synthesis of GelMA followed a modified procedure, reported previously in Ref. [11] .
In order to use GelMA as the printing material the following steps have to be made: 1) Photoinitiator, which induces formation of the hydrogel network while exposing the material onto UV radiation has to be added (See Fig. 1a ). This step is crucial for the purpose of forming the solid structure in the 3D printing procedure. In our studies, the material was doped with the Irgacure2959 photo-initiator. The Irgacure2959 has been mixed with GelMA in the 1/10 proportion.
2) The 10 % solution of GelMA+Irgacure2959 with PBS has to be prepared. 3) Stirring (at the temperature around 50 deg C) for 15-20 min is required to obtain a homogenous solution.
The process of formation of the hydrogel networks has been tested with use of the UV LED source Nichia NSHU591B -UV 365 nm intended to be employed in the prototype of the 3D bioprinter. The power emitted by the diode with the 10 degrees viewing angle is around 3 mW. The drops (0,05 mL) of the solution have been exposed onto the UV light source placed at the distance of 4 mm. The solution has been therefore exposed to approximately 750 mW/cm 2 UV light flux. In has been verified that material forms the hydrogel network after exposition times greater than around 120 s. After this time the material became insoluble. The obtained times of curing have to be reduced by at least by the factor of 100 in order to meet expectations of the final application. This presumably can be achieved by increasing concentration of the photoinitiator and value of UV light flux. Moreover, it is worth noticing that application of the UV irradiation in the process of formation of the hydrogel network has significant restriction while applied to bioprinting. Namely, living cells cannot be deposited simultaneously with the formation of scaffold due to destructive impact of the UV radiation.
Construction of the 3D Bioprinter Prototype. The mechanical construction of the proposed 3D
bioprinter is similar to the standard FDM 3D printers. In case of the FDM method, the filament is deposited layer-by-layer forming a topologically nontrivial 3D structure. The materials typically used in the FDM approach are thermoplasitc polymers such as ABS and PLA. The materials requires adequate heating of the extruder. In case of the later, the melting temperature is around 180 deg C, 105 deg C for the former.
The main difference between our construction and the FDM 3D printers is at the level of the extruder. The printing material is now the methacrylated gelatin (GelMA). To form the 3D solid Solid State Phenomena Vol. 237 223 hydrogel network, it has to be UV cured at the moment of deposition. This is realized with use of a UV light source, in our case, the UV LED Nichia NSHU591B (365 nm) described before. The role of the nozzle is played by a pipette tip. In the construction, the standard 200microL pipette tip with the nozzle diameter 460 microns has been used. The tip is connected with the syringe by the TYGON 3350 ultra-pure biopharmaceuticalgrade silicone tubing of the internal diameter 0,8 mm. The syringe is placed in the heating block. The heater employed is the standard 40 W heater used in the FDM 3D printers to melt the printing material. The temperature stabilization is based on a real-time readout from the 100 ohms termistor placed in the heating block. Scheme of the material dosing system and the material deposition process is shown in Fig. 1b.   Fig. 1 a) Formation of the hydrogel network as a result of the UV curing. b) Scheme of the material dosing system and the nozzle of the 3D biopriner. c) Overview of the 3D bioprinter prototype.
The crucial issue relevant for 3D bioprinters is the resolution of printing. In this case, two essential factors can be distinguished: 1) the mechanical resolution of the positioning of the extruder, 2) the resolution of the deposition -related in particular to the diameter of the nozzle. The resolution of positioning of the commercial 3D printers reaches 200 microns while the typical diameters of the nozzles are 400 microns. This adds up to the resolution of the order of 500 microns in the x-y direction. The resolution in the z direction is associated with the vertical positioning of platform and reaches 25 microns.
In order to maximize the positioning resolution in the x-y directions at a minimal cost, the laser head positioning mechanisms from old CD/DVD drivers were used (such solution has been previously applied in the bioprinter constructed by the BioCurious group [12, 13] ). These are based on the bipolar stepper motors PL15S-20 equipped with a lead screw. The motor makes 20 steps per revolution and the lead screw is characterized by a 3mm/revolution pitch. Therefore, each step of the motor leads to the 150 micron displacement in the x-y plane. In the prototype, we have used 1/16 microstepping, which improves resolution of the positioning up to around 10 microns. With such resolution, the possibility of bioprinting models of the physiological structures is quite
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Advances in Manufacturing Engineering II realistic. In particular, capillaries, the thinest body's blood vessels have diameter of the order of 10 microns. The resolution of positioning in the z direction is even higher. In this direction the bipolar stepper motor PG1521-0504B equipped with a gear giving 0,175 deg per step (around 2057 steps per revolution) has been used. The motor is connected with the Tamiya 70171 3 mm diameter shalf having the 0,5 mm/revolution pitch. This gives an incredibly low displacement of around 0,3 microns/step, which has a chance to be reduced even further, by an order of magnitude in the microsteping mode. Due to backlashes in various parts of the mechanical construction, such resolution is, however, not possible to achieve in the current prototype. Overviev of the prototype is presented in Fig. 1c . It is worth stressing that in construction the rapid prototyping (3D printing technique based on PLA) has been broadly applied. The disadvantage is, however, that precision and quality of the 3D printed elements was not always sufficiently high. The electronics employed in the constructions of the bioprinter have been adopted from those used in many DIY 3D printers. Namely, the central control unit is the Arduino Mega development board. The board is equipped with the ATmega2560 microcontroller (clocked at 16 MHz) and the 256 KB Flash memory. The board is connected to a computer via a USB port. The RAMPS 1.4 board with the Pololu stepper drivers is designed to work with the 12 V bipolar stepper motors. The nominal voltages for the x-y motors PL15S-20 and the PG1521-0504B z-direction motor are 5 V (the coil resistance is 10 ohms). Because the Pololu stepper drivers at 12 V, the voltage has been sufficiently reduced by 15 ohms resistors.
At the software level, the suitably configured Marlin firmware [14] was used. In particular, it turned to be essential to adjust number of steps per seconds the z-direction as well implement geometry of the printing region. The Marlin firmware reads G-codes received from the slicer software. The free open source Cura [15] slicer has been used during the tests. The Cura software plays a role of the graphical interface with the device as well. 3D models in the stl format are readed.
The Current State of the Prototype and Printing Results. So far only test with water and liquid gelatine as the printing material have been executed. The tests proved efficiency of the positioning as well as the material dosing systems. It has been shown that while the nozzle is placed close to the bottom of the printing bed (Petri dish), the material can be smoothly distributed across the 2D surface. Tests with arranging the material in the z-direction have not been performed yet.
Summary. This paper summarizes progress in the construction of a 3D bioprinter and the development of the material it will use. The project described is undertaken at an interdisciplinary laboratory under the name Garage of Complexity [16] . Our prototype is not at the operational state yet, however numerous obstacles at various levels of the project have been overcome. In particular, the material allowing for formation of the 3D cell cultures have been developed. Furthermore, the sufficient precision of the nozzle positioning system has been achieved. The current UV curing times of the photoactivated material are, however, insufficiently low for rapid 3D printing. With the measured curing time of the order of 100 s, printing of 1 cm 3 sample with the resolution of 100 microns would take around 3 years! In turn, the 1 cm 3 sample printed with the target resolution of 10 microns corresponds to 10 9 3D pixels. The deposition+curing time has to be therefore reduced below 0,1 millisecond in order to print the sample within a reasonable period of one day. Achieving such values of times is a highly non-trivial task in the constructions adopting the FDM 3D printing technology combined with UV curing. The alternative methods, such as those based on digital optical projection stereolitography (DOPsL) [17] , may be therefore more adequate for high precision 3D bioprinting. Nevertheless, 3D biological structures printed with the resolution of the order of 100 microns may still have broad applicability in medicine, pharmaceutics and biotechnology. 
